Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Allen, Jamie"'
Autor:
Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Choudhury PP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Derkach A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Wiafe-Addai B; Peace and Love Hospital, Kumasi, Ghana., Awuah B; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Yarney J; Korle Bu Teaching Hospital, Accra, Ghana., Edusei L; Korle Bu Teaching Hospital, Accra, Ghana., Titiloye N; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Adjei E; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Vanderpuye V; Korle Bu Teaching Hospital, Accra, Ghana., Aitpillah F; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Dedey F; Korle Bu Teaching Hospital, Accra, Ghana., Oppong J; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Osei-Bonsu EB; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Duggan MA; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Brinton LA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Allen J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Luccarini C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Baynes C; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Carvalho S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Davis Lynn BC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Hicks BD; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Yeager M; Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Chatterjee N; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Biritwum R; University of Ghana, Accra, Ghana., Clegg-Lamptey JN; Korle Bu Teaching Hospital, Accra, Ghana., Nyarko K; University of Ghana, Accra, Ghana., Wiafe S; Loma Linda University, School of Public Health, Loma Linda, California., Ansong D; Komfo Anokye Teaching Hospital, Kumasi, Ghana., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Figueroa JD; Usher Institute and CRUK Edinburgh Centre, University of Edinburgh, Edinburgh, United Kingdom., Garcia-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2022 Aug 02; Vol. 31 (8), pp. 1593-1601.
Autor:
Morra, Anna, Mavaddat, Nasim, Muranen, Taru A, Ahearn, Thomas U, Allen, Jamie, Andrulis, Irene L, Auvinen, Päivi, Becher, Heiko, Behrens, Sabine, Blomqvist, Carl, Bojesen, Stig E, Bolla, Manjeet K, Brauch, Hiltrud, Camp, Nicola J, Carvalho, Sara, Castelao, Jose E, Cessna, Melissa H, Chang-Claude, Jenny, Chenevix-Trench, Georgia, NBCS Collaborators, Czene, Kamila, Decker, Brennan, Dennis, Joe, Dörk, Thilo, Dorling, Leila, Dunning, Alison M, Ekici, Arif B, Eriksson, Mikael, Evans, D Gareth, Fasching, Peter A, Figueroa, Jonine D, Flyger, Henrik, Gago-Dominguez, Manuela, García-Closas, Montserrat, Geurts-Giele, Willemina RR, Giles, Graham G, Guénel, Pascal, Gündert, Melanie, Hahnen, Eric, Hall, Per, Hamann, Ute, Harrington, Patricia A, He, Wei, Heikkilä, Päivi, Hooning, Maartje J, Hoppe, Reiner, Howell, Anthony, Humphreys, Keith, KConFab Investigators, Jakubowska, Anna, Jung, Audrey Y, Keeman, Renske, Kristensen, Vessela N, Lubiński, Jan, Mannermaa, Arto, Manoochehri, Mehdi, Manoukian, Siranoush, Margolin, Sara, Mavroudis, Dimitrios, Milne, Roger L, Mulligan, Anna Marie, Newman, William G, Park-Simon, Tjoung-Won, Peterlongo, Paolo, Pharoah, Paul DP, Rhenius, Valerie, Saloustros, Emmanouil, Sawyer, Elinor J, Schmutzler, Rita K, Shah, Mitul, Spurdle, Amanda B, Tomlinson, Ian, Truong, Thérèse, Van Veen, Elke M, Vreeswijk, Maaike PG, Wang, Qin, Wendt, Camilla, Yang, Xiaohong R, Nevanlinna, Heli, Devilee, Peter, Easton, Douglas F, Schmidt, Marjanka K
Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral breast cancer (CBC) risk and breast cancer-specific survival (BCSS) is scarce. The aim of this study was to ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a0f64d77cdad8cf68991710f47725ef
Autor:
Breast Cancer Association Consortium, Mavaddat, Nasim, Dorling, Leila, Carvalho, Sara, Allen, Jamie, González-Neira, Anna, Keeman, Renske, Bolla, Manjeet K, Dennis, Joe, Wang, Qin, Ahearn, Thomas U, Andrulis, Irene L, Beckmann, Matthias W, Behrens, Sabine, Benitez, Javier, Bermisheva, Marina, Blomqvist, Carl, Bogdanova, Natalia V, Bojesen, Stig E, Briceno, Ignacio, Brüning, Thomas, Camp, Nicola J, Campbell, Archie, Castelao, Jose E, Chang-Claude, Jenny, Chanock, Stephen J, Chenevix-Trench, Georgia, Christiansen, Hans, Czene, Kamila, Dörk, Thilo, Eriksson, Mikael, Evans, D Gareth, Fasching, Peter A, Figueroa, Jonine D, Flyger, Henrik, Gabrielson, Marike, Gago-Dominguez, Manuela, Geisler, Jürgen, Giles, Graham G, Guénel, Pascal, Hadjisavvas, Andreas, Hahnen, Eric, Hall, Per, Hamann, Ute, Hartikainen, Jaana M, Hartman, Mikael, Hoppe, Reiner, Howell, Anthony, Jakubowska, Anna, Jung, Audrey, Khusnutdinova, Elza K, Kristensen, Vessela N, Li, Jingmei, Lim, Swee Ho, Lindblom, Annika, Loizidou, Maria A, Lophatananon, Artitaya, Lubinski, Jan, Madsen, Michael J, Mannermaa, Arto, Manoochehri, Mehdi, Margolin, Sara, Mavroudis, Dimitrios, Milne, Roger L, Mohd Taib, Nur Aishah, Morra, Anna, Muir, Kenneth, Obi, Nadia, Osorio, Ana, Park-Simon, Tjoung-Won, Peterlongo, Paolo, Radice, Paolo, Saloustros, Emmanouil, Sawyer, Elinor J, Schmutzler, Rita K, Shah, Mitul, Sim, Xueling, Southey, Melissa C, Thorne, Heather, Tomlinson, Ian, Torres, Diana, Truong, Thérèse, Yip, Cheng Har, Spurdle, Amanda B, Vreeswijk, Maaike PG, Dunning, Alison M, García-Closas, Montserrat, Pharoah, Paul DP, Kvist, Anders, Muranen, Taru A, Nevanlinna, Heli, Teo, Soo Hwang, Devilee, Peter, Schmidt, Marjanka K, Easton, Douglas F
Publikováno v:
Breast Cancer Association Consortium 2022, ' Pathology of tumors associated with pathogenic germline variants in 9 breast cancer susceptibility genes ', JAMA Oncology, vol. 8, no. 3, e216744 . https://doi.org/10.1001/jamaoncol.2021.6744
JAMA Oncology, 8(3). AMER MEDICAL ASSOC
JAMA Oncology
JAMA Oncology, 8(3). AMER MEDICAL ASSOC
JAMA Oncology
Key Points Question What breast tumor characteristics are associated with rare pathogenic protein truncating or missense variants in breast cancer susceptibility genes? Findings In this case-control study involving 46 387 control participants and 42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d5fb15af741541ab1b6e6f26f8f3d46
https://www.repository.cam.ac.uk/handle/1810/331404
https://www.repository.cam.ac.uk/handle/1810/331404
Autor:
Wen, Wei Xiong, Allen, Jamie, Lai, Kah Nyin, Mariapun, Shivaani, Hasan, Siti Norhidayu, Ng, Pei Sze, Lee, Daphne Shin-Chi, Lee, Sheau Yee, Yoon, Sook-Yee, Lim, Joanna, Lau, Shao Yan, Decker, Brennan, Pooley, Karen, Dorling, Leila, Luccarini, Craig, Baynes, Caroline, Conroy, Don M, Harrington, Patricia, Simard, Jacques, Yip, Cheng Har, Mohd Taib, Nur Aishah, Ho, Weang Kee, Antoniou, Antonis C, Dunning, Alison M, Easton, Douglas F, Teo, Soo Hwang
Publikováno v:
Journal of Medical Genetics
BACKGROUND: Genetic testing for BRCA1 and BRCA2 is offered typically to selected women based on age of onset and family history of cancer. However, current internationally accepted genetic testing referral guidelines are built mostly on data from can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a3db9ac62bfc5e7292b16dc53752e82f
https://ora.ox.ac.uk/objects/uuid:e402bad9-fdcb-413a-b813-7d10a7767dd1
https://ora.ox.ac.uk/objects/uuid:e402bad9-fdcb-413a-b813-7d10a7767dd1
Autor:
Wen, Wei Xiong, Allen, Jamie, Lai, Kah Nyin, Mariapun, Shivaani, Hasan, Siti Norhidayu, Ng, Pei Sze, Lee, Daphne Shin-Chi, Lee, Sheau Yee, Yoon, Sook-Yee, Lim, Joanna, Lau, Shao Yan, Decker, Brennan, Pooley, Karen, Dorling, Leila, Luccarini, Craig, Baynes, Caroline, Conroy, Don M, Harrington, Patricia, Simard, Jacques, Yip, Cheng Har, Mohd Taib, Nur Aishah, Ho, Weang Kee, Antoniou, Antonis C, Dunning, Alison M, Easton, Douglas F, Teo, Soo Hwang
BACKGROUND: Genetic testing for BRCA1 and BRCA2 is offered typically to selected women based on age of onset and family history of cancer. However, current internationally accepted genetic testing referral guidelines are built mostly on data from can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65589c466d9cc5d27fcba9b650b22a9c
Autor:
Thomas U. Ahearn, Parichoy Pal Choudhury, Andriy Derkach, Beatrice Wiafe-Addai, Baffour Awuah, Joel Yarney, Lawrence Edusei, Nicholas Titiloye, Ernest Adjei, Verna Vanderpuye, Francis Aitpillah, Florence Dedey, Joseph Oppong, Ernest Baawuah Osei-Bonsu, Máire A. Duggan, Louise A. Brinton, Jamie Allen, Craig Luccarini, Caroline Baynes, Sara Carvalho, Alison M. Dunning, Brittny C. Davis Lynn, Stephen J. Chanock, Belynda D. Hicks, Meredith Yeager, Nilanjan Chatterjee, Richard Biritwum, Joe Nat Clegg-Lamptey, Kofi Nyarko, Seth Wiafe, Daniel Ansong, Douglas F. Easton, Jonine D. Figueroa, Montserrat Garcia-Closas
Publikováno v:
Ahearn, T, Choudhury, P P, Derkach, A, Addai Wiafe, B, Awuah, B, Yarney, J, Edusei, L, Titiloye, N, Adjei, E, Vanderpuye, V, Aitpillah, F, Dedey, F, Oppong, J, Osei-bonsu, E B, Duggan, M A, Brinton, L A, Allen, J, Luccarini, C, Baynes, C, Carvalho, S, Dunning, A M, Davis Lynn, B C, Chanock, S J, Hicks, B, Yeager, M, Chatterjee, N, Biritwum, R B, Clegg-Lamptey, J-N, Nyarko, K, Wiafe, S, Ansong, D, Easton, D F, Figueroa, J D & Garcia-Closas, M 2022, ' Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations ', Cancer Epidemiology, Biomarkers & Prevention, vol. 31, no. 8, pp. 1593-1601 . https://doi.org/10.1158/1055-9965.EPI-21-1397
Background: Risk estimates for women carrying germline mutations in breast cancer susceptibility genes are mainly based on studies of European ancestry women. Methods: We investigated associations between pathogenic variants (PV) in 34 genes with bre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cce4aef3f837c76b3b4805475c81f4ba